Otonomy OTIC

Quarterly report 2022-Q3
added 11-10-2022

Otonomy DIO Ratio 2011-2026 | OTIC

Annual DIO Ratio Otonomy

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
112	69.7	-	-	0.707	315	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
315	0.707	124

Quarterly DIO Ratio Otonomy

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	148	135	-	-	-	102	-	-	-	-	-	-	-	1.01	-	382	275	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
382	1.01	174

DIO Ratio of other stocks in the Biotechnology industry

	Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
	Exelixis EXEL	96.1	$ 48.43	9.03 %	$ 13.2 B	USA
	Fortress Biotech FBIO	210	$ 2.56	3.96 %	$ 71.4 M	USA
	Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
	Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
	Galapagos NV GLPG	0.915	$ 28.78	1.36 %	$ 2.69 B	Belgium
	Grifols, S.A. GRFS	0.000171	$ 8.41	1.69 %	$ 6.83 B	Spain
	Ionis Pharmaceuticals IONS	259	$ 76.96	2.27 %	$ 12.3 B	USA
	Kamada Ltd. KMDA	166	$ 8.3	1.1 %	$ 260 M	Israel
	Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
	Ligand Pharmaceuticals Incorporated LGND	235	$ 229.83	-1.06 %	$ 4.2 B	USA
	ACADIA Pharmaceuticals ACAD	295	$ 22.32	-0.13 %	$ 3.7 B	USA
	MannKind Corporation MNKD	430	$ 3.68	28.5 %	$ 1.12 B	USA
	Esperion Therapeutics ESPR	2.46 K	$ 3.13	0.55 %	$ 651 M	USA
	Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
	Albireo Pharma ALBO	26.1	-	-0.23 %	$ 916 M	USA
	Arcutis Biotherapeutics ARQT	185	$ 23.86	1.88 %	$ 3.04 B	USA
	Puma Biotechnology PBYI	44.7	$ 7.5	2.04 %	$ 375 M	USA